GLP-1 drugs could cut mortality rates in US and UK, Swiss Re says
Reinsurance News - Sep 18, 2025
Swiss Re, a reinsurance company based in Zurich, has released new research suggesting that GLP-1 weight-loss medications could substantially reduce mortality rates in the United States and the United Kingdom over the next two decades. According to the company’s projections, if these drugs are widely...
Recommended Articles
Posted: Sep 18, 2025
The London reinsurance market faces a looming crisis due to a lack of new talent. A recent survey by...
Posted: Sep 18, 2025
Sompo, a provider of commercial and consumer property and casualty re/insurance, has announced the a...
Posted: Sep 18, 2025
Berkshire Hathaway Specialty Insurance (BHSI) has entered the Accident & Health Market in the UK...